ACADIA Pharmaceuticals Inc.

NASDAQ:ACAD

Biotechnology

Healthcare
$17.59 -0.60%

-$0.13 today

Market cap
$3.04B
Beta
0.83
P/E (TTM)
9.7
EPS (TTM)
$2.20
52W Low $19.69High $28.35

Volume 1.45M

Average 1.66M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.56B

FY 2025 · Annual

+31.7% YoY

Liabilities

$336.81M

FY 2025 · Annual

-26.0% YoY

Equity

$1.23B

FY 2025 · Annual

+67.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents147.44M114.85M188.66M319.59M177.7M
Short-term Investments373.27M301.98M250.21M436.4M641.99M
Net Receivables65.34M63.08M102.35M104.7M148.23M
Inventory7.88M6.64M35.82M21.95M34.67M
Other Current Assets00000
Total Current Assets617.82M507.94M616.13M938.32M1.06B
Property, Plant & Equipment (Net)66.32M61.59M56.47M50.79M54.87M
Goodwill00000
Intangible Assets0065.49M119.78M108.89M
Long-term Investments3.6M12.97M5.77M8.77M7.85M
Tax Assets0000249.88M
Other Non-current Assets12.38M5.31M5.1M70.1M80.6M
Total Non-current Assets82.3M79.88M132.83M249.44M502.08M
Total Assets700.12M587.81M748.96M1.19B1.56B
Account Payables6.88M12.75M17.54M16.19M10.9M
Short-term Debt009.41M011.63M
Tax Payables0377K1.56M12.02M0
Deferred Revenue00000
Other Current Liabilities25.9M49.51M92.31M36.55M67.83M
Total Current Liabilities96.07M125.63M254.25M394.87M277.11M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.03M9.07M15.15M18.06M19.14M
Total Non-current Liabilities63.16M61.77M62.95M60.09M59.69M
Total Liabilities159.23M187.4M317.2M454.96M336.81M
Common Stock16K16K16K16K16K
Retained Earnings(2.15B)(2.37B)(2.43B)(2.2B)(1.81B)
Accumulated OCI(192K)(975K)24K292K1.45M
Other Stockholders Equity00000
Minority Interest00000
Total Equity540.89M400.41M431.76M732.79M1.23B
Total Debt64.43M62M57.21M52M52.19M
Net Debt(83.01M)(52.85M)(131.45M)(267.59M)(125.51M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$976.4M
Receivables$161.0M
Inventory$40.4M
Other Current$90.6M
Total Current Assets$1.3B
PP&E (Net)$85.9M
Intangible Assets$135.5M
Tax Assets$226.7M
Other Non-current$77.7M
Total Non-current Assets$525.7M
Total Assets$1.8B

Analysis

Selected assets total $1.8B for Latest. The largest visible component is Cash & Equivalents at $976.4M, about 54.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 4, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
8-KCurrent reportOct 23, 2026

How much cash does ACAD have?

ACADIA Pharmaceuticals Inc. (ACAD) reported $177.69M in cash and equivalents in fiscal 2025.

How much debt does ACAD carry?

ACADIA Pharmaceuticals Inc. (ACAD) reported $52.19M of total debt, with net debt of -$125.51M.